previous reference ID: 60 next reference

CandActCFTR used public reference

The following publication reference has been reported to contain CFTR related structural information.
"S Noel" "C Bouckaert" "P Wallemacq" "B Dhooghe" "T Leal" "A Capron"


Below you will find all the structures identified in the publication. Be warned that this does not imply any activity. n=3

ID: 5
InChIKey: LUKBXSAWLPMMSZ-OWOJBTEDSA-N
SMILES: C1=CC(=CC=C1/C=C/C2=CC(=CC(=C2)O)O)O

biological descriptors:

CFTR relevance: CFTR corrector

Category:
Influence on CFTR function enhances CFTR function
Order of interaction unknown
subcellular compartment Apical membrane & subapical compartment

chemical graph of compound 5



CID is 445154
synonyms found at PubChem are:
resveratrol, 501-36-0, trans-resveratrol, 3,4',5-Trihydroxystilbene, (E)-5-(4-Hydroxystyryl)benzene-1,3-diol, 3,5,4'-Trihydroxystilbene, (E)-resveratrol, 3,4',5-Stilbenetriol, Resvida, 3,4',5-Trihydroxy-trans-stilbene, 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol, SRT-501, SRT501, Resveratol, SRT 501, 3,5,4'-Trihydroxy-trans-stilbene, 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol, 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol, 3,4',5-trihydroxy-stilbene, Resveratrol, natural, UNII-Q369O8926L, CHEBI:45713, trans-3,4',5-trihydroxystilbene, (E)-5-(p-Hydroxystyryl)resorcinol, trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene, 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol, CHEMBL165, NSC 327430, (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol, MLS000069735, 1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)-, LUKBXSAWLPMMSZ-OWOJBTEDSA-N, KUC104385N, PREVENTION 8 (RESVERATROL), C14H12O3, trans-3,4',5 - trihydroxystilbene, NSC327430, KSC-10-164, Q369O8926L, 5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol, RM-1812, trans-3,4′,5-Trihydroxystilbene, SMR000058206, R 5010, DSSTox_CID_11980, DSSTox_RID_78898, DSSTox_GSID_31980, CU-01000001503-3, (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol, (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol, 1,3-Benzenediol, 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-, MFCD00133799, STL, SR-01000000163, 5-[(1E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol, CHEBI:27881, CCRIS 8952, HSDB 7571, 3fts, 4jaz, 4qer, Resveratrol, E-, Resveratrol,(S), Stilbene, 2f, TaxusChinensisiRehd, NCGC00015894-02, CAS-501-36-0, Prestwick_619, Trans-3,4&prime, Resveratrol, trans-, Resveratrol, synthetic, Opera_ID_586, AC1L9HIC, Prestwick2_000508, Prestwick3_000508, Spectrum5_000552, D0U3EP, Lopac0_001111, REGID_for_CID_6240, SCHEMBL19425, BSPBio_000435, BSPBio_001114, BSPBio_003461, MLS001055357, MLS001076538, MLS001424228, MLS002207121, MLS002222231, ARONIS24568, SPECTRUM1502223, BPBio1_000479, cid_445154, GTPL8741, SGCUT00007, trans-Stilbene-3,4',5-triol, ZINC6787, Resveratrol, analytical standard, DTXSID4031980, REGID_for_CID_445154, BDBM23926, Resveratrol, >=99% (HPLC), BBC/741, BIK9013, 2l98, MolPort-002-499-801, BCPP000091, HMS1362H15, HMS1569F17, HMS1792H15, HMS1921N04, HMS1990H15, HMS2052I09, HMS2096F17, HMS2232A18, HMS3263O04, HMS3403H15, HMS3649A20, ACT09778, BCP01416, to_000079, ZX-AS004941, ZX-AT013797, Tox21_110257, Tox21_201374, Tox21_303376, Tox21_501111, ABP000376, AC-727, AN-865, BBL028252, BS0159, CCG-38874, CR-003, GP2549, GP5884, LMPK13090005, s1396, SBB055452, STL146386, AKOS005720936, Tox21_110257_1, ACN-034773, API0000480, CS-1050, DB02709, KS-5047, LP01111, LS-2146, MCULE-5678456463, NC00349, NSC-327430, OR46018, RP17549, SDCCGMLS-0002998.P003, IDI1_002152, Resveratrol solution, 100 mM in DMSO, NCGC00017352-05, NCGC00017352-06, NCGC00017352-07, NCGC00017352-08, NCGC00017352-09, NCGC00017352-10, NCGC00017352-11, NCGC00017352-12, NCGC00017352-13, NCGC00017352-14, NCGC00017352-15, NCGC00017352-16, NCGC00017352-17, NCGC00017352-18, NCGC00017352-19, NCGC00017352-24, NCGC00024003-00, NCGC00024003-04, NCGC00024003-05, NCGC00024003-06, NCGC00024003-07, NCGC00024003-08, NCGC00024003-09, NCGC00024003-10, NCGC00024003-11, NCGC00024003-12, NCGC00024003-13, NCGC00024003-14, NCGC00257465-01, NCGC00258925-01, NCGC00261796-01, 375823-41-9, 4CN-0696, AJ-08292, AK-39118, AS-12413, BC202036, BR-39118, CC-34242, CJ-00111, CPD000058206, HY-16561, KB-02515, SAM001246888, SC-11924, ST057251, SY014849, ZB000650, AB0006623, AX8004672, ST2408097, TL8003323, EU-0101111, FT-0082623, N1848, R0071, Resveratrol, Vetec(TM) reagent grade, 98%, 01R360, C03582, J10118, N88795, 5-[2-(4-hydroxyphenyl)vinyl]-1,3-benzenediol, AB00052942-29, AB00052942_31, A827984, 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzoldiol, I06-0437, SR-01000000163-3, SR-01000000163-4, SR-01000000163-9, 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol, 5-[(E)-2-(4-Hydroxyphenyl)ethenyl]benzol-1,3-diol, 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzenediol, 5[(E)-2-(4-Hydroxyphenyl)-vinyl]benzene 1,3-diol, BRD-K25591257-001-01-2, BRD-K80738081-001-06-2, BRD-K80738081-001-07-0, BRD-K80738081-001-09-6, BRD-K80738081-001-10-4, BRD-K80738081-001-23-7, SR-01000000163-10, SR-01000000163-11, SR-01000000163-16, (E)-1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene, (E)1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene, 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3,benzenediol, Resveratrol, certified reference material, TraceCERT(R), 1,3-Benzenediol, 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-, Resveratrol, European Pharmacopoeia (EP) Reference Standard, 533C1DA0-4104-42B5-9D32-9265F40857E4, trans-Resveratrol, United States Pharmacopeia (USP) Reference Standard, 3,4',5-Trihydroxy-trans-stilbene 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol, (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol, InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1, trans-3,5,4'-Trihydroxystilbene3,4',5-Stilbenetrioltrans-Resveratrol(E)-5-(p-Hydroxystyryl)resorcinol(E)-5-(4-hydroxystyryl)benzene-1,3-diol

ID: 16
InChIKey: JWZZKOKVBUJMES-UHFFFAOYSA-N
SMILES: CC(C)NCC(C1=CC(=C(C=C1)O)O)O

biological descriptors:

CFTR relevance: stimulates Cl- conductance as agonist of β2 adrenergic receptor

Category:
Influence on CFTR function enhances CFTR function
Order of interaction indirect
subcellular compartment Apical membrane & subapical compartment

chemical graph of compound 16



CID is 3779
synonyms found at PubChem are:
isoproterenol, Isoprenaline, Isoprenalin, Norisodrine, Novodrin, Isopropydrin, Isopropylarterenol, Asiprenol, Assiprenol, Bellasthman, Respifral, Aludrin, Aludrine, Asmalar, Isadrine, N-Isopropylnoradrenaline, Bronkephrine, Isonorene, Isopropyladrenaline, Lomupren, Neodrenal, Proternol, N-Isopropylnorepinephrine, Isopropylnorepinephrine, 7683-59-2, neo-Epinine, Isonorin, Isorenin, Saventrine, Isopropylnoradrenaline, Isopropyl noradrenaline, Racemic isoprenaline, dl-Isadrine, Isuprel, Racemic isoproterenol, (+-)-Isoproterenol, Vapo-N-iso, Epinephrine isopropyl homolog, Isoprenalinum, Isoproterenolum, Aleudrine, Isupren, (+-)-Isoprenaline, dl-Ipr, Isoprenalina, Isadrin, Isoproterenol [JAN], Dihydroxyphenylethanolisopropylamine, WIN 5162, DL(+-)-Isoproterenol, Medihaler-ISO, dl-Isopropylnoradrenaline, DL-Isopropylnorepinephrine, dl-N-Isopropylnoradrenaline, Isoprenalinum [INN-Latin], Isoprenalina [INN-Spanish], Isoproterenol Chloride, 1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol, ICI 46399, l-Isoproterenol, d-Isoprenaline, d-Isoproterenol, alpha-(Isopropylaminomethyl)protocatechuyl alcohol, Isuprel Mistometer, N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine, (S)-Isoproterenol, (+)-Isoprenaline, d-Isopropylarterenol, Aleudrin, 1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol, Isoprenaline (INN), ISOPROP, CCRIS 3081, 4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol, l-Isopropylnoradrenaline, NSC 9975, EINECS 231-687-7, NSC 33791, (S)-(+)-Isoproterenol, Isoproterenol sulfate, Isopropylaminomethyl-3,4-dihydroxyphenyl carbinol, CHEMBL434, d-N-Isopropylnorepinephrine, 1,2-Benzenediol, 4-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]-, BRN 2213857, 3,4-Dihydroxy-alpha-((isopropylamino)methyl)benzyl alcohol, 4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol, CHEBI:64317, 1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, JWZZKOKVBUJMES-UHFFFAOYSA-N, (S)-Isoprenaline, Isopropylaminomethyl(3,4-dihydroxyphenyl)carbinol, NSC33791, (+)-Isoproterenol, Isoprenaline [INN], Protocatechuyl alcohol, alpha-(isopropylaminomethyl)-, DL-ISOPROTERENOL, NCGC00015558-06, 3,4-Dihydroxy-.alpha.-(isopropylaminomethyl)-benzyl alcohol, Protocatechuyl alcohol,-, Isoprenaline sulfate, Isuprel (TN), DSSTox_CID_3175, 1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, (+-)-, BENZYL ALCOHOL, 3,4-DIHYDROXY-alpha-((ISOPROPYLAMINO)METHYL)-, (+-)-, DSSTox_RID_76904, DSSTox_GSID_23175, 149-53-1, .alpha.-(Isopropylaminomoethyl)protocatechuyl alcohol, 4-(1-Hydroxy-2(isopropylamino)ethyl)-benzene 1,2-diol, 4-(1-Hydroxy-2-(isopropylamino)ethyl)benzene-1,2-diol, 3,4-dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol, WLN: QR BQ DYQ1MY1&1, 3,4-Dihydroxy-.alpha.-[(isopropylamino)methyl]benzyl alcohol, 4-{1-hydroxy-2-[(1-methylethyl)amino]ethyl}benzene-1,2-diol, Benzyl alcohol, 3,4-dihydroxy-alpha-((isopropylamino)methyl)-, CAS-7683-59-2, 1, 4-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]-, 4-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,2-diol, 4-{1-hydroxy-2-[(methylethyl)amino]ethyl}benzene-1,2-diol, Benzyl alcohol,4-dihydroxy-.alpha.-[(isopropylamino)methyl]-, Isoproterenol-l, Isoproterenol;, Isoprenalinesulphate, Isoproterenol (-), Isoproterenol,(+), DL-isoprenaline HCl, ISOPROTERONOL, Isuprel (Salt/Mix), Izadrin (Salt/Mix), Euspiran (Salt/Mix), (+/-)-isoprenaline, (+/-)-isoproterenol, Spectrum_000949, AC1L1GOZ, AC1Q1QBS, 6700-39-6, Prestwick0_001097, Prestwick1_001097, Prestwick2_001097, Spectrum2_001061, Spectrum3_000474, Spectrum4_000024, Spectrum5_000880, (.+/-.)-Isoprenaline, (.+/-.)-Isoproterenol, D0I8FI, D0IF0C, D0P1IS, SCHEMBL4165, DL(.+/-.)-Isoproterenol, Lopac0_000711, Oprea1_009434, BSPBio_002208, GTPL536, KBioGR_000427, KBioSS_001429, 3-13-00-02387 (Beilstein Handbook Reference), DivK1c_000894, SPBio_001042, SPBio_003057, SGCUT00015, BENZYL ALCOHOL, 3,4-DIHYDROXY-alpha-((ISOPROPYLAMINO)METHYL)-, (+)-, DTXSID4023175, BDBM25392, KBio1_000894, KBio2_001429, KBio2_003997, KBio2_006565, KBio3_001428, NSC9975, NINDS_000894, HMS2089A12, BCP09043, NSC-9975, to_000062, (A+/-)-Isoproterenol hydrochloride, Tox21_110172, AS1409, NSC-33791, PDSP1_001425, PDSP2_001409, SBB005855, AKOS015913894, Tox21_110172_1, API0006523, CCG-204727, CCG-204796, DB01064, MCULE-6061231962, IDI1_000894, NCGC00015558-04, NCGC00015558-05, NCGC00015558-07, NCGC00015558-08, NCGC00015558-09, NCGC00015558-10, NCGC00015558-11, NCGC00015558-12, NCGC00015558-14, NCGC00016665-02, NCGC00025274-03, NCGC00025274-04, NCGC00162220-01, LS-42866, LS-42868, LS-42869, ST077771, SBI-0050689.P004, FT-0724367, C07056, D08090, EN300-148243, AB00053487-09, AB00053487-10, AB00053487_11, AB00053487_12, 683I592, alpha-(Isopropylaminomoethyl)protocatechuyl alcohol, L000936, .alpha.-(Isopropylaminomethyl)protocatechuyl alcohol, I14-45263, Protocatechuyl alcohol,.alpha.-(isopropylamino-methyl),-, 3,4-dihydroxy-alpha-[(isopropylamino)methyl]-benzyl alcohol, 4-[1-Hydroxy-2-(isopropylamino)ethyl]-1,2-benzenediol #, N-Isopropyl-.beta.-dihydroxyphenyl-.beta.-hydroxyethylamine, 4-[1-hydroxy-2-(isopropylamino)ethyl]pyrocatechol;hydrochloride, 4-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,2-diol, 4-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,2-diol, 2, Benzyl alcohol, 3,4-dihydroxy-.alpha.-((isopropylamino)methyl)-, 1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)- (9CI), 1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-(9CI), 1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, (S)-, 1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, (S)-(9CI), 46388-38-9

ID: 1963
InChIKey: RKUNBYITZUJHSG-PJPHBNEVSA-N
SMILES: CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3

biological descriptors:

CFTR relevance: salivary secretion inhibitor

Category:
Influence on CFTR function none
Order of interaction unknown
subcellular compartment unknown

chemical graph of compound 1963



CID is 174174
synonyms found at PubChem are:
ATROPINE, Tropine tropate, dl-Hyoscyamine, Atropin, Atropen, dl-Tropyltropate, Atropinol, Atropina, Eyesules, Isopto-atropine, Troyl tropate, hyoscyamine, Atropin [German], 51-55-8, Atropina [Italian], Atropin-flexiolen, (+,-)-Tropyl tropate, DL-Tropyl tropate, (+-)-hyoscyamine, Tropine, tropate (ester), (+-)-atropine, Tropic acid, ester with tropine, Cytospaz, (+/-)-Atropine, Atropine sulfate, CCRIS 3080, Atropine (USP), Atropine [BAN], Isopto Atropine, (+/-)-Hyoscyamine, Tropic acid, 3-alpha-tropanyl ester, Belladenal, Atropair, Atrosulf, Atropt, Minims, Urised, Minims Atropine, Atropine Care, HSDB 2199, Bellergal-S, Neo-Diophen, Ocu-Tropine, DL-Tropanyl 2-hydroxy-1-phenylpropionate, I-Tropine, Anaspaz, Atropen (TN), 2-Phenylhydracrylic acid 3-alpha-tropanyl ester, L-Hyoscyamine, Protamine & Atropine, AI3-60219, beta-Phenyl-gamma-oxypropionsaure-tropyl-ester [German], (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate, 1alphaH,5alphaH-Tropan-3alpha-ol (+-)-tropate (ester), beta-Phenyl-gamma-oxypropionsaeure-tropyl-ester [German], (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate, tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate, EINECS 200-104-8, Tropine (+/-)-tropate, atropinum sulphuricum, 8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate, Atropine Sulfate S.O.P., Daturine, Hyospaz, Hyosyne, Levbid, l-Atropine, MLS000069795, Symax Duotab, (+)-HYOSCYAMINE, Hyoscyamine sulfate, 1-Hyoscyamine, Levsinex SR, CHEBI:16684, Levsin SL, Symax SL, Symax SR, 8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate, (+)-Atropine, [(1S,5R)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate, Hyoscyamine [BAN], endo-(+/-)-alpha-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, d1-hyoscyamine, R-(+)-Hyoscyamine, atropinium cation, Benzeneacetic acid, alpha-(hydroxymethyl)-8-methyl-8-azabicyclo(3,2,1)oct-3-yl ester, endo-(+-)-, NCGC00017333-03, SMR000058248, atropinium(1+), (S)-(-)-Hyoscyamine, DSSTox_CID_113, 1-alpha-H,5-alpha-H-Tropan-3-alpha-ol (+-)-tropate (ester) (8CI), Atropine Sulfate Ansyr Plastic Syringe, AB00694549-11, [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate, DSSTox_RID_75375, DSSTox_GSID_20113, Hyocyamine, Buwecon, Donnamar, Egacene, Gastrosed, Levsinex, Neoquess, Peptard, Benzeneacetic acid, alpha-(hydroxymethyl)-, (3-endo)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, Benzeneacetic acid, alpha-(hydroxymethyl)-, 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, endo-(+-)-, Atropine, 3(S)-endo-Isomer, Symax, l-Hyopscyamine, L-Hyoscamine, Scopolia extract, Tropine, (-)-tropate (ester), C17H23NO3, 1-alpha-H,5-alpha-H-Tropan-3-alpha-ol (+-)-tropate (ester), Hyoscyamine (USP), (-)-Tropic Acid Ester with Tropine, 8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropionate, Donnagel, Egazil, Nulev, b eta-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, CAS-51-55-8, Tropic acid, (-)-, ester with tropine, Benzeneacetic acid, alpha-(hydroxymethyl)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, endo-(+-)-, Tropine, (-)-tropate, NP-010662, Atropine [USP:BAN], alpha-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, HYOSCYAMINE HCl, Mydriasine, Atropinum, ropine tropate, MFCD00022622, (1S,5R)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate, (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl (2S)-3-hydroxy-2-phenylpropanoate, Hyospasmol (TN), Cystospaz (TN), NCGC00159345-02, 3-tropoyloxytropane, Donnamar (TN), Neoquess (TN), 13269-35-7, Anaspaz (TN), Buwecon (TN), Levbid (TN), Levsin (TN), HyoMax (TN), Symax (TN), NuLev (TN), H 9002, (3-endo,8-syn)-3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-methyl-8-azoniabicyclo[3.2.1]octane, Opera_ID_1088, beta-Phenyl-gamma-oxypropionsaure-tropyl-ester, bmse000649, D0RD5W, D0RG3O, beta-Phenyl-gamma-oxypropionsaeure-tropyl-ester, AC1L5AX3, AC1Q3XL2, SCHEMBL2812, Atropine, analytical standard, GTPL320, MLS001148094, MLS002695888, CHEMBL475124, CHEMBL517712, cid_174174, MEGxp0_001878, DTXSID4020113, ACon1_000046, CHEBI:78734, (1R,3r,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-hydroxy-2-phenylpropanoate, Atropine, >=95.0% (NT), MolPort-001-742-593, RKUNBYITZUJHSG-SPUOUPEWSA-N, BDBM200229, HMS2089A16, HMS2231G17, HMS3259M13, BCP15060, HY-B1205, OIN, Atropine, >=99% (TLC), powder, Tox21_110816, Tox21_111590, Tox21_200487, BDBM50403547, GP2470, SBB005985, AKOS015955538, CS-4834, DB00572, LS-7203, NC00493, OR22908, RL00080, NCGC00017333-02, NCGC00017333-04, NCGC00017333-05, NCGC00017333-06, NCGC00142514-01, NCGC00142514-03, NCGC00258041-01, NCGC00385525-01, Benzeneacetic acid, alpha-(hydroxymethyl)- 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester endo-(+-)-, CPD001906768, SAM002554885, ST057178, Atropine, meets USP testing specifications, TR-000361, C1504, FT-0602865, FT-0627165, C01479, D00113, AB00694549-12, AB00694549_14, rac-tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate, BRD-A27290375-001-01-8, BRD-A27290375-330-01-1, Atropine, European Pharmacopoeia (EP) Reference Standard, [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenyl-propanoate, [(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenyl-propanoate, alpha-Hydroxymethylphenylacetic acid (1R,5S)-8-methyl-8-azabicyclo[3.2.1]octane-3-yl ester, Atropine for peak identification, European Pharmacopoeia (EP) Reference Standard, rac-(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate, (1beta,3alpha,5beta)-3-[(3-Hydroxy-1-oxo-2-phenylpropyl)oxy]-8-methyl-8-azabicyclo[3.2.1]octane, 78597-12-3, Benzeneacetic acid, alpha-(hydroxymethyl)- (3-endo)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, Benzeneacetic acid, alpha-(hydroxymethyl)-, 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, endo-(+/-)-, Benzeneacetic acid, alpha-(hydroxymethyl)-8-methyl-8-azabicyclo [3.2.1]oct-3-yl ester, endo-(+/-)-, Benzeneacetic acid, alpha-(hydroxymethyl)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester endo-(+-)-, endo-( inverted exclamation markA)-|A-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester